510(k) Report

510(k) · Cleared

Cleared

Fogarty Corkscrew Catheters; Fogarty Graft Thrombectomy Catheters

K233619510(k) TraditionalCleared May 20, 2024189-day reviewClass II21 CFR 870.5150

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Edwards Lifesciences · DXE Catheter, Embolectomy

Cleared on May 20, 2024 as substantially equivalent to K901625 (Baxter Healthcare Corp, 1990) and 1 other predicate after a 189-day review. Its family tree reaches back 1 generation to 1990.

Decided
May 20, 2024
Review
189 days
Class
Class II
Product code
DXE
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K901625 (1990). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1995: 1 other ancestorK901625 · Fogarty Arterial Embolectomy II Catheter · Baxter Healthcare Corp · 1990 · recalled19901995200020052010201520202025
Other ancestors, by generation 1 generation back: 1 other ancestor K901625 · Fogarty Arterial Embolectomy II Catheter · Baxter Healthcare Corp · 1990 · recalled0
  1. Root · 1 generation backK901625 Fogarty Arterial Embolectomy II CatheterBaxter Healthcare Corp · 1990 · Recalled
  2. This deviceK233619 Fogarty Corkscrew Catheters; Fogarty Graft Thrombectomy CathetersEdwards Lifesciences · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K901625Fogarty Arterial Embolectomy II CatheterBaxter Healthcare Corp19901
0 (this device)K233619Fogarty Corkscrew Catheters; Fogarty Graft Thrombectomy CathetersEdwards Lifesciences2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199510
FIG. 1 — Lineage of K233619, 1990–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DXE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DXE device

  1. #1 K240078 Fogarty Thru-Lumen Embolectomy Catheterscore 7.9 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K901625Fogarty Arterial Embolectomy II Catheter
Summary page 5
…21 CFR 870.5150; Embolectomy catheter Regulation Name Product Code DXE Regulation Class II Fogarty Arterial Embolectomy II Catheters (K901625, cleared on July 06, 1990) Predicate Device Intramed® Graft Thrombectomy Instrument Set (K942457, cleared on February 07,…
Baxter Healthcare Corp19901
*K942457Graft Thrombectomy Instruments
Summary page 5
…ss II Fogarty Arterial Embolectomy II Catheters (K901625, cleared on July 06, 1990) Predicate Device Intramed® Graft Thrombectomy Instrument Set (K942457, cleared on February 07, 1995) Fogarty Corkscrew Catheters: The Fogarty…
Intramed Laboratories, Inc.1995—

Also cleared against K901625: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • 1 of the 2 ancestors has a recall of any class.
  • 1 other device also cites its predicate K901625.

How does its category compare?

All DXE devices

DXE Catheter, Embolectomy: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · DXE

5in 2024

2008: 12010: 22015: 12017: 22020: 12021: 12022: 12024: 5
2007high 5 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DXE

173in 2024

2024: 173 days median
2007high 173 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DXE

1in 2023

2007: 32009: 52010: 12011: 12015: 132021: 4, 4 Class I2022: 32023: 12026 (partial year): 2
2007high 13 (2015) · low 0 (2008)2026

Class I (4 since 2007) Class II/III not classified

Adverse event reports per year · DXE

306in 2025

2007: 1672008: 1342009: 1242010: 1362011: 1642012: 2002013: 1502014: 1922015: 2662016: 7962017: 7702018: 6152019: 5942020: 5472021: 3332022: 4632023: 4362024: 3772025: 306
2007high 796 (2016) · low 124 (2009)2025

MAUDE reports naming product code DXE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—3167
20081—0134
20090—5124
20102—1136
20110—1164
20120—0200
20130—0150
20140—0192
20151—13266
20160—0796
20172—0770
20180—0615
20190—0594
20201—0547
20211—4 (4)333
20221—3463
20230—1436
202451730377
20250—0306
20260—2—

What is it indicated for?

The Fogarty Corkscrew Catheter is indicated for use in adult patients with emboli/thrombi in the peripheral arterial vasculature in either native vessels or synthetic grafts. The Fogarty Graft Thrombectomy Catheter is indicated for use in adult patients for the removal of organized thrombus and adherent non‐thrombotic material from synthetic bypass grafts, specifically synthetic arteriovenous grafts used for dialysis access and synthetic grafts for…

Read the full statement (112 words)

The Fogarty Corkscrew Catheter is indicated for use in adult patients with emboli/thrombi in the peripheral arterial vasculature in either native vessels or synthetic grafts.

The Fogarty Graft Thrombectomy Catheter is indicated for use in adult patients for the removal of organized thrombus and adherent non‐thrombotic material from synthetic bypass grafts, specifically synthetic arteriovenous grafts used for dialysis access and synthetic grafts for ileo‐femoral bypass in the peripheral arterial vasculature. General indications for arterial reconstruction of an obstructed graft include disabling claudication, ischemic pain at rest, or ischemic skin lesions or gangrene. General indications for reconstruction of a synthetic AV fistula internal bridge graft include the inability to properly dialyse the patient.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K233619: Fogarty Corkscrew Catheters; Fogarty Graft Thrombectomy Catheters.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K233619

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026